- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about AZN
Recent news which mentions AZN
2 Top Biotech Stocks to Buy Right Now
October 14, 2022
From Motley Fool
3 Incredibly Cheap Blue Chip Stocks to Buy Right Now
October 13, 2022
From Motley Fool
2 No-Brainer Stocks to Buy Right Now for Less Than $100
October 12, 2022
From Motley Fool
Is Seagen Stock a Buy Now?
October 12, 2022
From Motley Fool
From Benzinga
Twitter May Drop Clickable Hashtags, AstraZeneca's Nasal COVID-19 Vaccine Fails Trial, Coinbase Gets Singapore Nod: Top Stories Tuesday, Oct. 11
October 11, 2022
From Benzinga
From Benzinga
Have $2,000? 2 Market Crash-Ready Stocks to Buy
October 09, 2022
From Motley Fool
2 Healthcare Stocks That Could Help Make You a Fortune
October 08, 2022
From Motley Fool
From MarketWatch
War over drug-cost assistance traps sickest patients in the middle
October 03, 2022
From MarketWatch
Will Chart Analysts Notice Bad Omen on AstraZeneca's Chart
October 03, 2022
Tickers
AZN
From Benzinga
Why Is LogicBio (LOGC) Stock Up 600% Today?
October 03, 2022
From InvestorPlace
Biotech Company Pleased With Results Of Early Testing Demonstrating Vaccine Potential For Multiple Sclerosis
October 03, 2022
From Benzinga
Why LogicBio Therapeutics Stock Is Soaring Today
October 03, 2022
From Benzinga
Why Are LogicBio Therapeutics Shares Skyrocketing Today?
October 03, 2022
From Benzinga
From Benzinga
What This News Means for Merck
October 01, 2022
From Motley Fool
PhaseBio Might Have To Return Global Rights To Its Lead Program
September 28, 2022
From Benzinga
7 Large-Cap Stocks With Sustained Dividend Growth Potential
September 28, 2022
From InvestorPlace
Japan Approves AstraZeneca's Two Treatments For Asthma, Rare Form Of Cancer
September 27, 2022
From Benzinga
7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’
September 27, 2022
From InvestorPlace
US Stock Futures Rise Ahead Of Economic Reports, Fed Speakers; Crude Oil Rises 1%
September 27, 2022
From Benzinga
Adding $100 to These 7 Stocks Would Be a Genius Move Right Now
September 27, 2022
From Motley Fool
Burberry Finance Chief Joins GSK As First Woman CFO
September 26, 2022
From Benzinga
European Stocks Are Left In Shambles From Russia-Ukraine War: It May Be Time To Buy These 2 High Yielders
September 25, 2022
From Benzinga
Should Growth Investors Buy This Little-Known Stock?
September 24, 2022
From Motley Fool
AstraZeneca Pulls Plug On Ionis Pharma-Partnered Cholesterol Med
September 23, 2022
From Benzinga
With Upcoming Contentious Meeting, This Analyst Cuts Price Target On Spectrum Pharma
September 21, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.